NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

MDXG

Mimedx Group Inc

Apr 25 • 04:00PM ET

6.91

Dollar change +0.11
Percentage change 1.62	%

Healthcare • Biotechnology • USA • NASD

Peers: VRTX BIO PODD SAGE RGEN HAE CNMD CYRX APYX AXGN

| Held by: VTI IWM VXF XBI VTWO IWN SCHA IWO VHT DFAS

Scroll to Statements

Index	RUT	P/E	24.29	EPS (ttm)	0.28	Insider Own	21.35%	Shs Outstand	146.93M	Perf Week	3.44%
Market Cap	1.02B	Forward P/E	19.30	EPS next Y	0.36	Insider Trans	-0.65%	Shs Float	115.91M	Perf Month	-9.55%
Income	42.42M	PEG	3.15	EPS next Q	0.05	Inst Own	49.78%	Short Float	4.06%	Perf Quarter	-21.39%
Sales	348.88M	P/S	2.92	EPS this Y	-3.57%	Inst Trans	4.65%	Short Ratio	8.38	Perf Half Y	20.80%
Book/sh	1.31	P/B	5.26	EPS next Y	32.59%	ROA	16.70%	Short Interest	4.71M	Perf Year	6.14%
Cash/sh	0.71	P/C	9.75	EPS next 5Y	7.72%	ROE	25.01%	52W Range	5.47 - 10.14	Perf YTD	-28.17%
Dividend Est.	-	P/FCF	15.78	EPS past 5Y	-	ROI	19.67%	52W High	-31.85%	Beta	1.85
Dividend TTM	-	Quick Ratio	3.69	Sales past 5Y	3.85%	Gross Margin	82.56%	52W Low	26.33%	ATR (14)	0.30
Dividend Ex-Date	-	Current Ratio	4.21	EPS Y/Y TTM	-32.91%	Oper. Margin	17.00%	RSI (14)	42.58	Volatility	2.63% 4.44%
Employees	837	Debt/Eq	0.13	Sales Y/Y TTM	8.52%	Profit Margin	12.16%	Recom	1.00	Target Price	13.00
Option/Short	Yes / Yes	LT Debt/Eq	0.12	EPS Q/Q	-85.79%	Payout	0.00%	Rel Volume	0.82	Prev Close	6.80
Sales Surprise	3.90%	EPS Surprise	-30.56%	Sales Q/Q	7.00%	Earnings	Apr 30 AMC	Avg Volume	562.25K	Price	6.91
SMA20	-1.35%	SMA50	-9.29%	SMA200	-8.36%	Trades		Volume	458,532	Change	1.62%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-02-24	Initiated	Cantor Fitzgerald	Overweight	$11
Mar-07-24	Initiated	Lake Street	Buy	$12
Oct-27-23	Initiated	Craig Hallum	Buy	$12
Oct-13-22	Initiated	Mizuho	Buy	$7
Jul-26-21	Initiated	Northland Capital	Outperform	$23
Mar-19-21	Initiated	H.C. Wainwright	Buy	$20

Apr-16-25 08:00AM	MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30 (GlobeNewswire)
Apr-10-25 04:01PM	MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences (GlobeNewswire)
Mar-31-25 05:45PM	BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Mar-20-25 01:58AM	Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.7% Jump Turn into More Strength? (Zacks)
Feb-27-25 08:22AM	Q4 2024 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
08:00AM	Loading…
08:00AM	MIMEDX to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
02:22AM	MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-26-25 05:55PM	MiMedx (MDXG) Q4 Earnings Meet Estimates (Zacks)
05:04PM	MiMedx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results (GlobeNewswire)
Feb-25-25 10:37AM	Earnings To Watch: MiMedx Group Inc (MDXG) Reports Q4 2024 Result (GuruFocus.com)
Feb-05-25 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26 (GlobeNewswire)
Dec-17-24 09:00AM	MIMEDX Files Patent Infringement Lawsuit Against Surgenex (GlobeNewswire)
Dec-04-24 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-20-24 09:55AM	How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12% (Zacks)
09:15AM	Loading…
Nov-14-24 09:15AM	MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs (GlobeNewswire) +23.56%
Nov-04-24 09:55AM	Can MiMedx (MDXG) Climb 77.92% to Reach the Level Wall Street Analysts Expect? (Zacks)
08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-31-24 05:00AM	MiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong International Growth and New ... (GuruFocus.com) +20.39%
Oct-30-24 05:25PM	MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
04:26PM	MiMedx: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Third Quarter 2024 Operating and Financial Results (GlobeNewswire)
Oct-14-24 08:00AM	MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 (GlobeNewswire)
Oct-09-24 03:36PM	MiMedx Group Inc (MDXG) Q2 2024 Earnings Call Highlights: Strong Sales Growth Amid Market Challenges (GuruFocus.com)
Oct-08-24 04:01PM	MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue (GlobeNewswire)
Oct-01-24 04:01PM	MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall (GlobeNewswire)
Sep-11-24 01:03PM	EX-MiMEDX EMPLOYEES ALLEGE MiMEDX 'PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS' (PR Newswire)
Sep-04-24 04:23PM	THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES' (PR Newswire)
Aug-27-24 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-26-24 09:30AM	DEFENDANT FIGHTS BACK AGAINST MiMEDX 'BLATANT INTIMIDATION' NON-COMPETE SUIT (PR Newswire)
04:22PM	Loading…
Jul-31-24 04:22PM	MiMedx: Q2 Earnings Snapshot (Associated Press Finance) -10.34%
04:02PM	MIMEDX Announces Launch of HELIOGEN Fibrillar Collagen Matrix (GlobeNewswire)
04:01PM	MIMEDX Announces Second Quarter 2024 Operating and Financial Results (GlobeNewswire)
Jul-22-24 08:10AM	MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports (GlobeNewswire)
Jul-17-24 08:00AM	MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31 (GlobeNewswire)
08:00AM	Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives (GlobeNewswire)
Jul-01-24 02:18PM	7 Undervalued Biotech Stocks to Buy for Big-Time Returns (InvestorPlace)
Jun-26-24 04:01PM	MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer (GlobeNewswire)
May-20-24 06:00AM	4 Stocks to Watch in the Booming Regenerative Medicine Market (News Direct)
May-15-24 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-02-24 04:10PM	MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 09:33AM	Q1 2024 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents) +18.67%
03:30AM	MiMedx Group Inc (MDXG) Q1 2024 Earnings Call Transcript Highlights: Strong Financial ... (GuruFocus.com)
Apr-30-24 08:55PM	MDXG Stock Earnings: MiMedx Group Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:13PM	MiMedx: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces First Quarter 2024 Operating and Financial Results (GlobeNewswire)
Apr-16-24 08:00AM	MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30 (GlobeNewswire)
Apr-01-24 04:37PM	Spectral AI, Inc. (NASDAQ:MDAI) Q4 2023 Earnings Call Transcript (Insider Monkey) -7.65%
Mar-27-24 08:00AM	MIMEDX Provides Update on AXIOFILL Request for Designation ( RFD ) from FDA (GlobeNewswire)
Mar-20-24 07:00AM	MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing (GlobeNewswire)
Mar-13-24 08:00AM	MIMEDX Introduces E-Commerce and Account Management Platform (GlobeNewswire)
Mar-04-24 08:00AM	MIMEDX Announces Appointment of Two New Independent Directors (GlobeNewswire)
Feb-29-24 10:49AM	MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 04:55PM	MiMedx Group Inc (MDXG) Reports Strong Year-Over-Year Sales Growth and Net Income Surge in Q4 ... (GuruFocus.com)
04:41PM	MiMedx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results (GlobeNewswire)
Feb-21-24 11:51PM	MiMedx Group Inc Insider Sells Shares (GuruFocus.com)
Feb-20-24 08:00AM	MIMEDX to Present at TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-13-24 12:58PM	Get Rich Quick With These 3 Biotech Stocks to Buy Now (InvestorPlace)
Feb-12-24 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28 (GlobeNewswire)
Jan-22-24 08:00AM	MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing (GlobeNewswire)
Jan-17-24 10:25AM	MiMedx Group Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm (GlobeNewswire)
Dec-29-23 05:12PM	MiMedx says US FDA's warning letter for Axiofill not related to safety (Reuters) -10.26%
05:00PM	MIMEDX Provides AXIOFILL Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook (GlobeNewswire)
Dec-28-23 08:00AM	MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock (GlobeNewswire)
Nov-13-23 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 08:00AM	MIMEDX to Highlight Published Data at SAWC Fall (GlobeNewswire)
Oct-31-23 09:09AM	MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:28AM	Q3 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
06:50AM	MDXG: Xenografts and Synthetics Options for Expansion (Zacks)
Oct-30-23 06:03PM	MiMedx Group Inc (MDXG) Reports 20.7% Increase in Q3 2023 Net Sales (GuruFocus.com)
04:50PM	MiMedx: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Third Quarter 2023 Operating and Financial Results (GlobeNewswire)
Oct-27-23 10:01AM	Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls (The Fly)
Oct-16-23 08:00AM	MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30 (GlobeNewswire)
Sep-26-23 08:00AM	MIMEDX Announces Launch of EPIEFFECT (GlobeNewswire)
Sep-05-23 08:00AM	MIMEDX to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-15-23 04:01PM	MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study (GlobeNewswire)
Aug-08-23 02:05PM	Institutional owners may ignore MiMedx Group, Inc.'s (NASDAQ:MDXG) recent US$68m market cap decline as longer-term profits stay in the green (Simply Wall St.)
Aug-02-23 08:53AM	Q2 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
06:36AM	MDXG: Beat and a Raise (Zacks)
Aug-01-23 04:07PM	MiMedx: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Second Quarter 2023 Operating and Financial Results (GlobeNewswire)
Jul-26-23 01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE)
Jul-18-23 08:00AM	MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1 (GlobeNewswire)
Jul-11-23 08:30AM	MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case (GlobeNewswire)
Jul-05-23 08:00AM	MIMEDX Appoints Doug Rice as Chief Financial Officer (GlobeNewswire)
Jul-03-23 03:59AM	5 hot insider trades & hedge fund hits: Buffett picks up more Occidental shares (Investing.com)
Jun-27-23 06:46AM	Daily Vickers Top Buyers & Sellers for 06/27/2023 (Argus Research)
Jun-22-23 11:13AM	MDXG: KOA Program Discontinued (Zacks Small Cap Research)
Jun-20-23 04:01PM	MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability (GlobeNewswire) +7.18%
May-25-23 01:29PM	Breakeven On The Horizon For MiMedx Group, Inc. (NASDAQ:MDXG) (Simply Wall St.)
May-03-23 09:22AM	Q1 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents) +39.37%
07:21AM	MDXG: 1Q:22 Financial Results (Zacks Small Cap Research)
May-02-23 04:17PM	MiMedx: Q1 Earnings Snapshot (AP Finance)
04:01PM	MIMEDX Announces First Quarter 2023 Operating and Financial Results (GlobeNewswire)
Apr-18-23 08:00AM	MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2 (GlobeNewswire)
Apr-13-23 08:29AM	Investors in MiMedx Group (NASDAQ:MDXG) have unfortunately lost 57% over the last five years (Simply Wall St.) +6.05%
Mar-23-23 04:01PM	MIMEDX Announces Chief Financial Officer Transition (GlobeNewswire)
Mar-16-23 08:00AM	MIMEDX Comments on Recent Data Brief Published by Office of Inspector General (GlobeNewswire)

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maersk-Moller Kimberly	Chief Commercial Officer	Mar 17 '25	Sale	8.04	1,759	14,142	309,077	Mar 20 06:09 AM
Hulse William Frank IV	General Counsel and CAO	Mar 13 '25	Sale	7.89	54,596	430,762	440,178	Mar 14 05:58 PM
Maersk-Moller Kimberly	Chief Commercial Officer	Mar 13 '25	Sale	7.89	4,106	32,396	310,836	Mar 14 05:56 PM
Hulse William Frank IV	General Counsel and CAO	Mar 10 '25	Sale	7.80	81,446	635,279	494,774	Mar 12 07:56 PM
Hulse William Frank IV	Officer	Mar 10 '25	Proposed Sale	7.94	81,446	646,681		Mar 10 01:40 PM
Maersk-Moller Kimberly	Chief Commercial Officer	Feb 28 '25	Sale	8.40	2,111	17,743	265,271	Mar 05 07:13 PM
Whitlow Ricci S	Chief Operating Officer	Feb 13 '25	Sale	8.28	61,420	508,558	403,019	Feb 18 05:36 PM
GARDNER PHYLLIS	Former Director	Oct 10 '24	Proposed Sale	5.52	30,000	165,637		Oct 10 04:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MDXG

Mimedx Group Inc

Upgrade your FINVIZ experience